Nanomedicine News RSS Feed - Nanomedicine

Diamond Nanocrystals Act as Temperature Sensors for Hyperlocalised Cancer Therapy

Diamond Nanocrystals Act as Temperature Sensors for Hyperlocalised Cancer Therapy

Precise targeting biological molecules, such as cancer cells, for treatment is a challenge, due to their sheer size. Now ,Taiwanese scientists have proposed an advanced solution, based on a novel combination of previously used techniques, which can potentially be applied to thermal cancer therapy. [More]
Sevion Enters Agreement with Malvern to Establish New Biopharmaceutical Applications Laboratory

Sevion Enters Agreement with Malvern to Establish New Biopharmaceutical Applications Laboratory

Sevion Therapeutics, Inc., a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, has entered into an agreement with Malvern Instruments establishing a new biopharmaceutical applications laboratory in the heart of San Diego’s biotechnology cluster. [More]
Novavax Reports Top-Line Data from Phase 2 Clinical Trial of Recombinant Quadrivalent Seasonal Influenza VLP Vaccine Candidate

Novavax Reports Top-Line Data from Phase 2 Clinical Trial of Recombinant Quadrivalent Seasonal Influenza VLP Vaccine Candidate

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 2 clinical trial of its recombinant quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate (Seasonal Influenza VLP). [More]
FDA Grants Orphan Drug Designation for Second NanoSmart Product Using Proprietary Drug Delivery Platform

FDA Grants Orphan Drug Designation for Second NanoSmart Product Using Proprietary Drug Delivery Platform

NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration (FDA) for a second drug product that uses NanoSmart's proprietary drug delivery platform. [More]
FDA Clears Ignyta's IND for RXDX-107 Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

FDA Clears Ignyta's IND for RXDX-107 Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Ignyta, Inc., a precision oncology biotechnology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) for Ignyta’s new chemical entity RXDX-107, a next-generation alkyl ester of bendamustine encapsulated in human serum albumin (HSA) to form nanoparticles. [More]
Researchers Aim to Grow Nanoflowers Seeded from Metal Nanoparticles Producing Fractals that Mimic Neurons

Researchers Aim to Grow Nanoflowers Seeded from Metal Nanoparticles Producing Fractals that Mimic Neurons

Richard Taylor's vision of using artificial fractal-based implants to restore sight to the blind -- part of a far-reaching concept that won an innovation award this year from the White House -- is now covered under a broad U.S. patent. [More]
MonoSol Rx Initiates Phase 2a Study for Midaform® Insulin PharmFilm®, MSL- 001

MonoSol Rx Initiates Phase 2a Study for Midaform® Insulin PharmFilm®, MSL- 001

MonoSol Rx, the developer of PharmFilm drug delivery technology, with its partner Midatech Pharma, announced today that it has initiated a Phase 2a study for Midaform® Insulin PharmFilm®, MSL- 001, with the dosing of its first patient. [More]
Matinas BioPharma Announces Presentation of Preclinical Data on Encochleated Atovaquone at IDWeek 2015

Matinas BioPharma Announces Presentation of Preclinical Data on Encochleated Atovaquone at IDWeek 2015

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections, today announced that preclinical data on encochleated atovaquone (CATQ) will be presented at IDWeek 2015 Oct. 7-11 in San Diego. [More]
New License Enables Use of Innova’s Lightning-Link and InnovaCoat GOLD Technologies in Mologic’s Kits

New License Enables Use of Innova’s Lightning-Link and InnovaCoat GOLD Technologies in Mologic’s Kits

Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, and Mologic, a specialist diagnostic development company and molecular reagent innovator, announced today the signing of a supply and licensing agreement for use of Innova’s Lightning-Link® and InnovaCoat® GOLD technologies as part of Mologic’s commercial assay development services and range of immunoassays. [More]
ACPHS to Host Symposium and Workshop on Latest Advances in Nanomedicine

ACPHS to Host Symposium and Workshop on Latest Advances in Nanomedicine

The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences (ACPHS) will host a Symposium and Workshop August 3-7 to explore the latest advances in the field of Nanomedicine. The event will take place in the Gozzo Student Center located on the ACPHS Campus. [More]